gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
Spine stereotactic radiosurgery as a promising modality in patients with metasta
Started by:
in: Radiation Treatments & Options
- 1
- 1
- 5 years, 3 months ago
-
Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomiz
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with ad
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Addition of Abraxane to Standard of Care May Prolong Survival for Advanced Bilia
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Telling Their Stories Through Posters
Started by:
in: Websites
- 1
- 1
- 5 years, 3 months ago
-
PD-L1 expression in extrahepatic biliary tract cancers: a comparative study usin
Started by:
in: New Developments
- 1
- 1
- 5 years, 3 months ago
-
Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, an
Started by:
in: Radiation Treatments & Options
- 1
- 1
- 5 years, 3 months ago
-
PD-L1 expression in extrahepatic biliary tract cancers: a comparative study usin
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Phase III BILCAP Trial Informs ASCO Guideline on Adjuvant Therapy for Resected B
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Evaluation of the utility of prognostic models for patients with resected hilar
Started by:
in: Surgery, Resection & Transplant Treatment Options
- 1
- 1
- 5 years, 3 months ago
-
Gold nano particles synthesized from Strychni semen and its anticancer activity
Started by:
in: New Developments
- 1
- 1
- 5 years, 3 months ago
-
The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Pote
Started by:
in: New Developments
- 1
- 1
- 5 years, 3 months ago
-
Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 a
Started by:
in: Chemotherapy & More
- 1
- 1
- 5 years, 3 months ago
-
Spine stereotactic radiosurgery as a promising modality in patients with metasta